Abstract
Aim—To use CD45RO immunohistochemistry to investigate the numbers of T lymphocytes found in sections of myocardium from a routine necropsy series, and to determine the incidence of myocarditis in this series.
Methods—Myocardial sections from 163 routine hospital necropsies were stained with CD45RO and the numbers of positive lymphocytes/mm2 were counted. The results were correlated with the H/E opinion and the clinical context of the necropsy.
Results—Most (143) cases showed low numbers (0–3) of CD45RO positive lymphocytes/mm2. Fifteen cases showed 7–13 positive lymphocytes/mm2, comprising a wide variety of clinical conditions, generally with no specific cardiac pathology. Five cases showed 14 or more positive lymphocytes/mm2, comprising one case of active myocarditis, three cases of cardiac transplant rejection, and one post-transplant lymphoproliferative disorder, all conditions in which large numbers of lymphocytes would be expected.
Conclusions—The incidence of myocarditis in our series was 0.6%. In most cases the normal myocardium has a low T lymphocyte count (0–3/mm2). In some cases immunohistochemistry shows more positive cells than would have been expected on light microscopy. Immunohistochemistry is a useful and reliable means of confirming a diagnosis of myocarditis. The results support the conclusion of the 1997 ISFC task force that 14 or more lymphocytes or macrophages/mm2 of myocardium in the appropriate clinical context is a reliable threshold for the diagnosis of chronic myocarditis.
Key Words: myocarditis • immunohistochemistry • T lymphocytes • necropsy
Full Text
The Full Text of this article is available as a PDF (102.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abelmann W. H. Myocarditis. N Engl J Med. 1966 Oct 13;275(15):832–contd. doi: 10.1056/NEJM196610132751509. [DOI] [PubMed] [Google Scholar]
- Aretz H. T., Billingham M. E., Edwards W. D., Factor S. M., Fallon J. T., Fenoglio J. J., Jr, Olsen E. G., Schoen F. J. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987 Jan;1(1):3–14. [PubMed] [Google Scholar]
- Aretz H. T. Myocarditis: the Dallas criteria. Hum Pathol. 1987 Jun;18(6):619–624. doi: 10.1016/s0046-8177(87)80363-5. [DOI] [PubMed] [Google Scholar]
- Bowles N. E., Towbin J. A. Molecular aspects of myocarditis. Curr Opin Cardiol. 1998 May;13(3):179–184. [PubMed] [Google Scholar]
- Caforio A. L., Goldman J. H., Haven A. J., Baig K. M., McKenna W. J. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol. 1996 May;54(2):157–163. doi: 10.1016/0167-5273(96)02593-4. [DOI] [PubMed] [Google Scholar]
- Cappato R., Alboni P., Codecà L., Guardigli G., Toselli T., Antonioli G. E. Direct and autonomically mediated effects of oral quinidine on RR/QT relation after an abrupt increase in heart rate. J Am Coll Cardiol. 1993 Jul;22(1):99–105. doi: 10.1016/0735-1097(93)90822-i. [DOI] [PubMed] [Google Scholar]
- Gravanis M. B., Sternby N. H. Incidence of myocarditis. A 10-year autopsy study from Malmö, Sweden. Arch Pathol Lab Med. 1991 Apr;115(4):390–392. [PubMed] [Google Scholar]
- Henke A., Huber S., Stelzner A., Whitton J. L. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol. 1995 Nov;69(11):6720–6728. doi: 10.1128/jvi.69.11.6720-6728.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KLINE I. K., KLINE T. S., SAPHIR O. Myocarditis in senescence. Am Heart J. 1963 Apr;65:446–457. doi: 10.1016/0002-8703(63)90094-2. [DOI] [PubMed] [Google Scholar]
- Kühl U., Noutsias M., Schultheiss H. P. Immunohistochemistry in dilated cardiomyopathy. Eur Heart J. 1995 Dec;16 (Suppl O):100–106. doi: 10.1093/eurheartj/16.suppl_o.100. [DOI] [PubMed] [Google Scholar]
- Kühl U., Noutsias M., Seeberg B., Schultheiss H. P. Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996 Mar;75(3):295–300. doi: 10.1136/hrt.75.3.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maisch B. Einteilung der Kardiomyopathien nach der WHO/ISFC Task Force--Mehr Fragen als Antworten? Med Klin (Munich) 1998 Apr 15;93(4):199–209. doi: 10.1007/BF03044794. [DOI] [PubMed] [Google Scholar]
- Malkiel S., Kuan A. P., Diamond B. Autoimmunity in heart disease: mechanisms and genetic susceptibility. Mol Med Today. 1996 Aug;2(8):336–342. doi: 10.1016/1357-4310(96)81799-0. [DOI] [PubMed] [Google Scholar]
- Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol. 1996 May;11(3):302–309. doi: 10.1097/00001573-199605000-00011. [DOI] [PubMed] [Google Scholar]
- Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide. Jpn Circ J. 1997 Apr;61(4):275–291. doi: 10.1253/jcj.61.275. [DOI] [PubMed] [Google Scholar]
- Mues B., Brisse B., Zwadlo G., Themann H., Bender F., Sorg C. Phenotyping of macrophages with monoclonal antibodies in endomyocardial biopsies as a new approach to diagnosis of myocarditis. Eur Heart J. 1990 Jul;11(7):619–627. doi: 10.1093/oxfordjournals.eurheartj.a059767. [DOI] [PubMed] [Google Scholar]
- Schwimmbeck P. L., Badorff C., Rohn G., Schulze K., Schultheiss H. P. The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol. 1996 May;54(2):117–125. doi: 10.1016/0167-5273(96)02588-0. [DOI] [PubMed] [Google Scholar]
- Yazaki Y., Isobe M., Yamazaki S., Sekiguchi M., Usuda N. Ultrastructural and immunohistochemical analysis of biopsy-proven chronic active mycocarditis with numerous clusters of lymphocytes. Virchows Arch. 1998 Aug;433(2):161–166. doi: 10.1007/s004280050231. [DOI] [PubMed] [Google Scholar]